Posts filtered by tags: Big Pharma[x]


 

Why vaccines should be compulsory

Imagine we develop a vaccine against the coronavirus (COVID-19). Suppose the vaccine has some very small chance of some serious side effects, for instance seizures. However, this vaccine can save millions of lives globally, in the same way as other vaccines do. You are the prime minister and you have to decide whether to make the vaccine compulsory. You know that many people are opposed to vaccines and especially compulsory vaccination. They would not vaccinate even if failure to vaccinate enoug...
Tags: Books, China, US, United States, Ethics, Italy, Korea, Philosophy, Vaccinations, Big Pharma, Arts & Humanities, Medical Mondays, CCO, Public Health Ethics, Therese Mikkelsen Skaar


Human testing of Johnson & Johnson coronavirus vaccine to begin in September

American drug maker Johnson & Johnson said Monday it plans to begin the human testing phase of its experimental coronavirus vaccine by September 2020, with plans to make it available for emergency use in early 2021. In January, J&J said it was already working on a possible coronavirus vaccine, using the same technologies with which scientists there developed an experimental Ebola vaccine. From Reuters: J&J also committed more than $1 billion of investment along with U.S. agency Biomedical ...
Tags: Post, Science, News, Medicine, Johnson, Vaccines, Reuters, Johnson Johnson, Big Pharma, Moderna Inc, Coronavirus, COVID-19, Covid19, Coronavirus Vaccine


Pharma Giant Gilead Retracts Request FDA Extend Monopoly Status on Experimental Covid-19 Drug

Pharmaceutical giant Gilead Sciences on Wednesday retracted its effort to score extended monopoly rights and tax breaks on its antiviral drug remdesivir, which scientists are evaluating as a possible treatment in the novel coronavirus pandemic.Read more...
Tags: Health, Science, Pharmaceuticals, Gilead Sciences, Big Pharma, Gilead, Coronavirus, Covid 19, Sars Cov 2, Remdesivir, Pharma Giant Gilead


After Trump touts chloroquine + hydroxychloroquine as COVID-19 cure, India pharma co to get reprieve from U.S. ban over quality concerns

• Three manufacturing plants of Ipca Laboratories get exemption • Agency had cited ‘systematic data manipulation’ at one plant This sounds fine, and I'm sure no Americans will be harmed. Everything is going great. At Bloomberg News, an important story today about all the bonkers demand for chloroquine and hydroxychloroquine, two unproven drugs for coronavirus and COVID-19 that Donald Trump has decided are the cure, or something. Trump wants large quantities of these drugs in the U.S. right a...
Tags: Health, Post, News, India, America, US news, Public Health, Fda, Pharma, Mumbai, Donald Trump, Trump, Bloomberg News, U S Food and Drug Administration, Big Pharma, IPCA


Big Pharma just pulled the plug on its first attempt to copy the buzzy startups that ship Viagra and hair-loss pills to your door

Bausch Health abruptly stopped offering prescriptions on its site Dermatology.com. The website offered drugs online to treat conditions like acne, wrinkles, and eczema, and launched just weeks ago. Bloomberg's Emma Court, who first reported the news, said that the move came after hundreds of dermatologists signed a petition to Bausch Health asking the company to shut down its service.  The $9 billion drugmaker was following a strategy similar to buzzy startups like Roman and Hims, which use on...
Tags: Trends, Bloomberg, Viagra, Big Pharma, Valeant Pharmaceuticals, Bausch, Ortho, Lux Capital, Emma Court, Gelesis, Bausch Health, Umar Afridi, Truepill, Bill Humphries, RxDefine, Chase Feiger


The inside story of how the $10 billion biotech Moderna developed a potential coronavirus vaccine in record time

The $10 billion biotech Moderna developed a potential coronavirus vaccine in record time, zooming past Big Pharma competitors. Stephane Bancel, the company's CEO, sat down with Business Insider to discuss the technology platform that drove its speed and how the company hopes to pioneer a new way of developing vaccines.  "The speed is one dimension, but the piece that excites me the most about this technology is we can do vaccines that cannot be done using traditional technology," Bancel said. ...
Tags: France, China, US, America, Trends, Nih, Wall Street Journal, Big Pharma, Moderna, Vaccine Research Center, Stéphane Bancel, Bancel, Massachusetts Stephane Bancel, Barney Graham, National Institutes of Health Graham


'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time (MRNA)

The $10 billion biotech Moderna developed a potential coronavirus vaccine in record time, zooming past Big Pharma competitors. The company's CEO Stephane Bancel sat down with Business Insider to discuss the technology platform that drove its speed, and how the company hopes to pioneer a new way of developing vaccines.  "The speed is one dimension, but the piece that excites me the most about this technology is we can do vaccines that cannot be done using traditional technology," Bancel said. T...
Tags: Amazon, Washington, France, China, Ipo, Massachusetts, US, Trends, Shanghai, Cambridge, Fda, Norwood, Anthony Fauci, Nih, Wall Street Journal, Polaroid


Big Pharma more profitable than most other large public firms

A large study published in the journal JAMA in March 2020 reports that large pharmaceutical companies make a much larger profit from their products than other large public companies. This is important because it indicates the potential to reduce drug prices while sustaining competitive and innovative drug development and marketing.
Tags: Health, Big Pharma, JAMA


The US is sprinting to develop a coronavirus vaccine or treatment. Here's how 7 top drugmakers are racing to tackle an outbreak that's spreading around the world.

As the coronavirus outbreak has exploded into a global public-health emergency, leading drugmakers have begun researching treatments and vaccines to stop the virus. The small biotech Moderna has leaped to the front of the race, sending a vaccine candidate to US health officials to start testing in people. Pharma giants like Johnson & Johnson and Sanofi are also in the early stages of developing potential vaccines. A vaccine would likely to take more than a year to reach mass distribution, rese...
Tags: New York, California, Washington, White House, China, Africa, US, Trends, Pennsylvania, Bill Gates, Who, World Health Organization, National Institutes of Health, GlaxoSmithKline, Pfizer, Pharma


Many States Still Can't Test Locally For Coronavirus Despite Promises From Trump Regime

Alex Azar, secretary of the Department of Health and Human Services (HHS), appeared on the Sunday political TV shows this weekend to reassure Americans that federal health authorities were prepared to tackle the coronavirus crisis, which has so far sickened at least 89 people in 12 states across the U.S. and killed…Read more...
Tags: South Korea, New York, Science, California, Cdc, Washington, Oregon, Fda, Donald Trump, Pandemics, Department of Health and Human Services HHS, Big Pharma, Eli Lilly, Outbreaks, Drug Companies, President Trump


The first family of Facebook, the most important charts in the world, and fintech dealmaking

Hello! One minute before midnight on December 29, 2017, one of Mark Zuckerberg's personal staffers got a phone call. So starts an explosive story from Rob Price and Becky Peterson, which shines a light on the sprawling family office of Mark Zuckerberg and his wife, Priscilla Chan. According to their reporting: Over the past three years, multiple personal aides to Mark Zuckerberg and Priscilla Chan have been accused of serious misconduct by their colleagues. One former staffer accused the manag...
Tags: Amazon, Facebook, Mark Zuckerberg, Elon Musk, Microsoft, US, America, Trends, Rebecca, Porsche, Hawaii, Bill Gates, Berkshire Hathaway, Goldman Sachs, Intuit, Jamie Dimon


A Coronavirus Vaccine Should Be Free, Not 'Affordable'

The Trump Administration’s early reaction to the outbreak of a new coronavirus that’s near certain to hit the U.S. hard hasn’t been great, to put it lightly.Read more...
Tags: Science, Vaccines, Greed, Big Pharma, Trump Administration, Coronavirus, Covid 19, Sars Cov 2


Dispensed: Coronavirus spreads, drugmakers scramble to respond, and the latest magic mushroom startups

Hello, Welcome to Dispensed, Business Insider's weekly healthcare newsletter. With Lydia Ramsey skiing the Colorado slopes, this week's edition is being written — for the very first time — by her colleague, Andrew Dunn. Are you new to the newsletter? You can sign up here.  And what a week for my first newsletter. Breathe in. Breathe out. Wash your hands. We've got a lot of coronavirus developments to go through, starting with speedy progress on developing a vaccine candidate.  How the buzzy b...
Tags: Colorado, California, China, US, Toronto, Trends, Fda, North America, Amgen, Gilead Sciences, Big Pharma, Lydia, Cambridge Massachusetts, Steve Jurvetson, The National Institutes of Health, Moderna


Why the price of insulin has skyrocketed in recent years

In the 1920s, Frederick Banting, one of the scientists who co-discovered insulin (and won a Nobel Prize for it) said, “Insulin does not belong to me, it belongs to the world.” He and the other scientists sold the patent for making insulin to the University of Toronto for $3. And yet today, this drug, which is needed to keep millions of people with diabetes alive, costs 700% more than it did two decades ago and many people can no longer afford it. What happened? It comes down to two reasons: a "l...
Tags: Post, News, Insulin, University of Toronto, Big Pharma, Sanofi, Alan Levine, Universal CC0, Frederick Banting, Eli Lilly Novo Nordisk, James Dinneen


How the buzzy biotech upstart Moderna sped past Big Pharma to develop the first potential coronavirus vaccine in just 42 days

In the sprint to develop vaccines for the coronavirus outbreak, the world's largest drugmakers have been lapped by a startup biotech.  It took 42 days for Moderna to turn the genomic sequence of the virus into a vaccine candidate and ship it to US health officials.  The National Institutes of Health will now start the first human trial in a matter of weeks, focused on safety. It will require months of additional study to know if the vaccine is safe and effective in protecting people against th...
Tags: White House, China, US, Trends, Shanghai, Anthony Fauci, Nih, Wuhan, Zika, Jpmorgan, Johnson Johnson, National Institutes of Health NIH, Big Pharma, Sanofi, Fauci, Fudan University


179D Tax Deduction Allocated from Government Buildings

On December 20, 2019, the President signed legislation reviving the Section 179D energy efficient commercial building tax deduction and while much has been written about the much needed boost to green building, little has been said about the enormous benefits available from government owned buildings. The § 179D federal tax deduction was brought back from the dead. This was Congress’ tax extenders bill bringing back to life expired tax provisions. This post will not consider the extended tax bre...
Tags: Energy, Law, Congress, Environmental, SEC, Green Building, Department Of Energy, Irs, Big Pharma, Stuart Kaplow, LEED, Federal State, Codes and Regulations, Kaplow, 179d, Section 179d


Dispensed: Big Pharma's plans to compete with buzzy startups, Sanofi's entrance to the coronavirus vaccine race, and a Medicare Advantage pitch deck

Welcome to Dispensed, Business Insider's weekly healthcare newsletter. This week, a closer look at pharma's into the DTC healthcare business.
Tags: Science, Big Pharma, Sanofi, Medicare Advantage


Big Pharma just started copying the buzzy startups that ship Viagra and hair-loss pills to your door, and it could be the start of a 'mega-trend'

The pharmaceutical company Bausch Health is now selling prescription drugs online to treat conditions like acne, wrinkles, and eczema. The $9 billion drugmaker is following a strategy similar to buzzy startups like Roman and Hims, which use online doctor visits to prescribe Viagra and hair-loss pills online. "I believe that we are ahead of a mega-trend here," Bill Humphries, president of Bausch's Ortho Dermatologics business, told Business Insider. Dermatology.com is tapping the healthcare tec...
Tags: Amazon, America, Trends, Walmart, Healthcare, Silicon Valley, Valeant, Big Pharma, Santa Monica California, Humphries, Bausch, Ortho, Philidor, Lux Capital, Joseph Papa, Gelesis


Coronavirus: Russian media hint at US conspiracy

Big Pharma and US intelligence are among the culprits in conspiracy theories aired by Russian TV.
Tags: News, US, Big Pharma


Cancer drugs are the most profitable for Big Pharma

A recent report from Evaluate shows oncological therapies were the most profitable in 2018. The report projects cancer drug sales to nearly double by 2024, pocketing a tidy $236.6 billion in profit. These projections come at a time when 42 percent of cancer patients lose their life savings to afford treatment. The pharmaceutical industry's top earners are cancer drugs — a sentence that will be read to the surprise of no one. When sussing out why oncological therapies cost so much, the usual ...
Tags: Health, Cancer, Markets, Merck, Humira, Public Health, Capitalism, Innovation, Fda, Health Care, Pharmaceuticals, Inequality, Consumerism, Roche, Big Pharma, JAMA


Microsoft's top healthcare exec says one of CEO Satya Nadella's biggest innovations was to 'violate the horizontal nature of Microsoft' and go after more specific customers (MSFT)

One of the biggest changes Satya Nadella has made at Microsoft is shifting the company from a focus on making general-purpose products to ones that can be tuned for specific industries, says Dr. Peter Lee, head of Microsoft Healthcare.  The idea is to focus on deepening its expertise in the industries to which it wants to sell — like healthcare, Dr. Lee's particular patch. The focus is apparent in Microsoft's recent hires from industries like healthcare, energy and financial services. Microsof...
Tags: Google, Microsoft, Satya Nadella, Samsung, Trends, Steve Ballmer, Bp, GlaxoSmithKline, Lee, Microsoft Research, Big Pharma, Nadella, Peter Lee, Greg Moore, Satya, Bill Borden


Walgreens was the worst stock in the Dow last year. Here's how the CEO is betting a partnership with a tech giant can help it recover.

Walgreens is having a tough time.  The pharmacy giant's stock dropped 10% so far this year, after its financial results missed Wall Street's expectations. The company finished 2019 as the worst-performing stock on the Dow Jones Industrial Average. Declining reimbursements for prescription drugs, competition with other retailers, as well as more sales going to online sellers like Amazon have put the retail pharmacy business in a rocky spot. Walgreens is betting that partnerships and an emphasis...
Tags: Amazon, Microsoft, US, Trends, Walgreens, Tennessee, Memphis, Cvs, Business Insider, Kroger, Jpmorgan, Knoxville, Humana, Big Pharma, UnitedHealth, Kehoe


US insurers, sick of being gouged by Big Pharma, will develop cheap generics

The US health insurance industry resents being on the receiving end of surprise bills and price-gouging, so Blue Cross/Blue Shield are spending $55m to have the nonprofit Civica Rx tool up to make generics of off-patent drugs whose sole manufacturers are shkreliing the prices into the stratosphere. Civica already supplies drugs to 1,200 hospitals. Drugmakers hiked prices 1,000% in massive price-fixing scheme, states allege In an interview with The New York Times, Civica board chairman ...
Tags: Health, Post, News, US, Petard, Big Pharma, Blue Cross Blue Shield, Civica, Dan Liljenquist, Medicare For All, Civica Rx, Beth Mole Ars Technica, That's Our Job, Usausasa, New York Times Civica


Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive

Daré Bioscience launched in 2015 with the aim of assembling a portfolio of novel women’s health products intended to pique interest from major pharmaceutical companies.Now the San Diego-based company has inked its first deal with Big Pharma, signing an agreement with German biopharma Bayer for its lead asset, a monthly non-hormonal form of birth control. Under terms announced Monday, Bayer will pay Daré an undisclosed upfront sum to secure the right to license its experimental contraceptive, Ov...
Tags: Deals, Startups, US, Trends, San Diego, Biotech, Life Sciences, Bayer, Licensing, Clinical Trials, Big Pharma, Dare, National blog main, San Diego blog main, San Diego top stories, Daré Bioscience


A top investor at Andreessen Horowitz shares why she's betting Big Pharma firms will have to make a big change to how they do business in 2020

Andreessen Horowitz general partner Julie Yoo thinks 2020 will be the year pharmaceutical companies get into the business of providing medical care.  "The next generation of therapeutic companies are going to have to build competency around care delivery and logistics," Yoo said. Yoo focuses on investing in all the ways healthcare is paid for and provided to people. Subscribe to Dispensed, Business Insider's weekly healthcare newsletter. Click here for more BI Prime stories. In 2020, pharmace...
Tags: Google, Amazon, Trends, Medicare, Andreessen Horowitz, Big Pharma, HIPAA, Yoo, Omada Health, Kyruus, Julie Yoo, Julie Yoo Andreessen Horowitz, HIPAA Yoo


These are Microsoft's 15 most significant hirings and departures of 2019 (MSFT)

Microsoft lost and hired important executives in 2019. Perhaps its most significant loss is artificial intelligence leader Harry Shum, who is leaving the company next month during a crucial time for the business. Microsoft's hiring choices reveal some of the company's priorities, including an overall trend of hiring people with expertise in the industries to which Microsoft wants to sell. Read below for Microsoft's 15 biggest hires and departures of the past year. Click here to read more BI Pr...
Tags: Apple, Google, Amazon, New York, Microsoft, Eric Holder, Satya Nadella, US, Samsung, Trends, Siri, Bloomberg, Netflix, Bp, GlaxoSmithKline, Hall


Apple Store employees feel like robots, Goldman's alt-investment 'storefront,' and a foolproof budget spreadsheet

Hello there! My name is Joe Ciolli, and I oversee the markets and investing teams at Business Insider. Your usual scribe Matt Turner is out on parental leave, so I'll be handling your weekly dispatch of the hottest and most thought-provoking business news and analysis. Before I get to the goods, I must offer you the opportunity to sign up for my team's weekly markets newsletter, aptly named Investing Insider. A few clicks and keystrokes can get you exclusive interviews, recommendations, and ana...
Tags: Apple, Amazon, Youtube, New York City, Trends, Walmart, Harvard, Warren Buffett, Fidelity, Silicon Valley, Michigan, Goldman Sachs, WeWork, Goldman, Blackstone, Apple Store


From Apple upping its healthcare ambitions to Walmart acquiring a health insurer, VCs shared the biggest surprises they're watching out for in 2020

2020 could bring a lot of surprises for healthcare companies — both good and bad. While gathering predictions for the year ahead, we asked 10 venture capitalists what they think would be the biggest surprises to hit healthcare in 2020. Those surprises could include some form of "Medicare for All" gaining traction, Amazon making a big healthcare deal, or Apple becoming a medical provider, they said. Subscribe to Dispensed, Business Insider's weekly healthcare newsletter. Click here for more BI ...
Tags: Apple, Google, Amazon, Obamacare, US, Trends, Walmart, House, Nancy Pelosi, Andreessen Horowitz, Nea, Venrock, Trump, Bush, Lux, Roberts


Big Pharma Continues New Year's Tradition of Squeezing U.S. Sick for Every Last Dime

Pharmaceutical giants celebrated the dawn of 2020 in the best way they know how: jacking up the prices of drugs for people in the U.S. that need them.Read more...
Tags: Health, Science, Medicine, Drugs, Health Care, Pharmaceuticals, Big Pharma


10 top healthcare VCs shared the biggest surprise that could rock 2020, from 'Medicare for All' to Amazon or Walmart buying a health insurer

2020 could bring a lot of surprises for healthcare companies — both good and bad. While gathering predictions for the year ahead, we asked 10 venture capitalists what they think would be the biggest surprises to hit healthcare in 2020. Those surprises could include some form of "Medicare for All" gaining traction, Amazon making a big healthcare deal, or Apple becoming a medical provider, they said. Subscribe to Dispensed, Business Insider's weekly healthcare newsletter. Click here for more BI ...
Tags: Apple, Google, Amazon, Obamacare, US, Trends, Walmart, House, Medicare, Nancy Pelosi, Andreessen Horowitz, Nea, Venrock, Trump, Bush, Lux